Drug profile · INN
warfarin sodium
WARFARIN SODIUM
warfarin sodium (WARFARIN SODIUM) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — warfarin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
warfarin sodium (WARFARIN SODIUM) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Primary target: Vitamin K epoxide reductase complex subunit 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is warfarin sodium?
warfarin sodium (WARFARIN SODIUM) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for warfarin sodium?
WARFARIN SODIUM is a marketed brand name for warfarin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of warfarin sodium?
warfarin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.